Synergetics USA Inc (NASDAQ:SURG)
| 4.77 Data as of Jan 29 |  -0.01 / -0.21%Today’s Change | 2.93 Today|||52-Week Range 4.99 | +9.66% Year-to-Date |
Latest SURG News | Press Releases
| FDA OKs DexCom Glucose Monitoring System with Share App - Analyst Blog Jan 28 / Zacks.com | Echo Therapeutics Restores Pact with MTIA, Issues Patent - Analyst Blog Jan 22 / Zacks.com |
| Abiomed Q3 Earnings Impress; Impella RP Gets FDA Approval - Analyst Blog Jan 28 / Zacks.com | Greatbatch (GB) Rides High on Strategic Investments - Analyst Blog Jan 22 / Zacks.com |
| Accuray (ARAY) Q2 Loss Wider than Expected, Revenues Lag - Analyst Blog Jan 28 / Zacks.com | Cantel Medical's MINNCARE HD Disinfectant Wins FDA Nod - Analyst Blog Jan 21 / Zacks.com |
| Quality Systems Beats Q3 Earnings on Revenue Strength - Analyst Blog Jan 27 / Zacks.com | Exactech Acquires Surgical Technology Partner BlueOrtho - Analyst Blog Jan 21 / Zacks.com |
| Falling Earnings Estimates Signal Weakness Ahead for Accuray (ARAY) - Tale of the Ta... Jan 27 / Zacks.com | NextGen Practice Management Wins EHNAC Accreditation - Analyst Blog Jan 21 / Zacks.com |
Today’s Trading
| Previous close | 4.78 |
| Today’s open | 4.73 |
| Day’s range | -- - -- |
| Volume | 32,453 |
| Average volume (3 months) | 78,881 |
| Market cap | $119.5M |
| Dividend yield | -- |
Data as of 01/29/2015
Growth & Valuation
| Earnings growth (last year) | +20.00% |
| Earnings growth (this year) | +47.22% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +2.84% |
| P/E ratio | 43.4 |
| Price/Sales | 1.71 |
| Price/Book | 1.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RVPRetractable Technolo... | +0.07 | +1.67% |
| ARDMAradigm Corp | +0.06 | +0.80% |
| LMATLeMaitre Vascular In... | +0.01 | +0.13% |
| --Ekso Bionics Holding... | -0.03 | -2.36% |
Data as of 3:58pm ET, 01/29/2015
Financials
| Next reporting date | March 10, 2015 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $64.3M |
| Annual profit (last year) | $3.1M |
| Net profit margin | 4.76% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director David M. Hable |
CFO, Secretary, Treasurer & Executive VP Pamela G. Boone |
Corporate headquarters O'Fallon, Missouri |
Forecasts
.